• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Nucleai, GoPath Diagnostics Partner to Power AI-Powered Digital Pathology

by Jasmine Pennic 04/08/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Nucleai Secures $14M to Enhance Clinical Trial Enrollment with Spatial AI Biomarker

What You Should Know: 

– Nucleai, a leader in spatial biology and AI, and GoPath Diagnostics, a leading provider of digital pathology and molecular diagnostics, announced a strategic collaboration today. 

– The partnership aims to revolutionize clinical trials, diagnostics, and research in oncology and immunology by combining their strengths in AI and real-world data.

Unlocking the Power of Spatial AI Biomarkers

Nucleai specializes in “spatial AI biomarkers.” This technology analyzes tissue samples to understand the complex communication and interaction between cells. By deciphering these “cellular conversations,” Nucleai’s AI can predict how patients will respond to specific treatments.

GoPath’s Expertise in Real-World Data and Diagnostics

GoPath Diagnostics brings extensive experience in digital pathology and molecular diagnostics to the table. They offer a full suite of services, including:

  • Digital Pathology: GoPath offers advanced digital tools for analyzing tissue samples.
  • Molecular Diagnostics: Their services include cutting-edge molecular testing for a deeper understanding of diseases.
  • Real-World Data: GoPath possesses a rich dataset of real-world patient information.

AI-powered Digital Pathology Solutions

By combining these strengths, Nucleai and GoPath aim to:

  • Develop AI-powered Digital Pathology Solutions: Nucleai’s AI will be integrated with GoPath’s digital pathology platform, creating a powerful solution for clinical trials and diagnostics.
  • Centralized, Secure Environment: The AI analysis will occur within a secure environment meeting the highest regulatory standards. This ensures data privacy and compliance.
  • Actionable Insights for Clinicians: The AI will provide clinicians with valuable insights to support patient care decisions throughout the treatment journey.
  • Biopharma Partner Support: The collaboration will streamline research for pharmaceutical companies by providing access to real-world data, AI capabilities, and comprehensive lab services.

Focus on Actionable Results

The partnership will initially focus on developing AI-powered pathology analysis tools that deliver practical, clinically relevant insights for multiple clinical trials and research studies in oncology and immunology. This includes areas like prostate cancer and inflammatory bowel disease.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Biomarkers

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |